Results 201 to 210 of about 1,955 (223)
Some of the next articles are maybe not open access.
Burosumab nell’ipofosfatemia XLH
L'Endocrinologo, 2020Marco Pitea, Elisa Sala, Stefano Mora
openaire +1 more source
Measuring FGF23 in patients treated with burosumab
Endocrine Abstracts, 2023Isabelle Piec +5 more
openaire +1 more source
Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia
Osteoporosis International, 2022Crotti C. +4 more
openaire +3 more sources
XLH: EU-Zulassung für Burosumab-Selbstverabreichung
Orthopädie & Rheuma, 2021openaire +1 more source
Abstract #999151: Burosumab Treatment For Tumor-Induced Osteomalacia
Endocrine Practice, 2021Juan Sarmiento, Daniel Englert
openaire +1 more source